April 24th, 2014 - Volume 28 - Issue 7
pp: 939-1080

Increased survival among HIV-1 and HIV-2 dual-infected individuals compared to HIV-1 single-infected individuals

Esbjörnsson, Joakim; Månsson, Fredrik; Kvist, Anders; More

AIDS. 28(7):949-957, April 24th, 2014.

HLA-B*35: 05 is a protective allele with a unique structure among HIV-1 CRF01_AE-infected Thais, in whom the B*57 frequency is low

Mori, Masahiko; Wichukchinda, Nuanjun; Miyahara, Reiko; More

AIDS. 28(7):959-967, April 24th, 2014.

Soluble CD14 is independently associated with coronary calcification and extent of subclinical vascular disease in treated HIV infection

Longenecker, Chris T.; Jiang, Ying; Orringer, Carl E.; More

AIDS. 28(7):969-977, April 24th, 2014.

Relationship of immunologic response to antiretroviral therapy with non-AIDS defining cancer incidence

Yanik, Elizabeth L.; Napravnik, Sonia; Cole, Stephen R.; More

AIDS. 28(7):979-987, April 24th, 2014.

Week 48 results from a randomized clinical trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate vs. efavirenz/emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV-1-infected adults

Cohen, Calvin; Wohl, David; Arribas, Jose R.; More

AIDS. 28(7):989-997, April 24th, 2014.

Findings in asymptomatic HIV-infected patients undergoing chest computed tomography testing: implications for lung cancer screening

Sigel, Keith; Wisnivesky, Juan; Shahrir, Shahida; More

AIDS. 28(7):1007-1014, April 24th, 2014.

Concise Communication

Reduced markers of HIV persistence and restricted HIV-specific immune responses after early antiretroviral therapy in children

Ananworanich, Jintanat; Puthanakit, Thanyawee; Suntarattiwong, Piyarat; More

AIDS. 28(7):1015-1020, April 24th, 2014.


Innate immunity cell activation in virologically suppressed HIV-infected maraviroc-treated patients

Dentone, Chiara; Di Biagio, Antonio; Parodi, Alessia; More

AIDS. 28(7):1071-1074, April 24th, 2014.